Correlation Between Rapport Therapeutics, and Apogee Enterprises
Can any of the company-specific risk be diversified away by investing in both Rapport Therapeutics, and Apogee Enterprises at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rapport Therapeutics, and Apogee Enterprises into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rapport Therapeutics, Common and Apogee Enterprises, you can compare the effects of market volatilities on Rapport Therapeutics, and Apogee Enterprises and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rapport Therapeutics, with a short position of Apogee Enterprises. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rapport Therapeutics, and Apogee Enterprises.
Diversification Opportunities for Rapport Therapeutics, and Apogee Enterprises
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Rapport and Apogee is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Rapport Therapeutics, Common and Apogee Enterprises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Enterprises and Rapport Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rapport Therapeutics, Common are associated (or correlated) with Apogee Enterprises. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Enterprises has no effect on the direction of Rapport Therapeutics, i.e., Rapport Therapeutics, and Apogee Enterprises go up and down completely randomly.
Pair Corralation between Rapport Therapeutics, and Apogee Enterprises
Given the investment horizon of 90 days Rapport Therapeutics, Common is expected to under-perform the Apogee Enterprises. But the stock apears to be less risky and, when comparing its historical volatility, Rapport Therapeutics, Common is 1.03 times less risky than Apogee Enterprises. The stock trades about -0.34 of its potential returns per unit of risk. The Apogee Enterprises is currently generating about -0.22 of returns per unit of risk over similar time horizon. If you would invest 7,128 in Apogee Enterprises on October 21, 2024 and sell it today you would lose (1,559) from holding Apogee Enterprises or give up 21.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rapport Therapeutics, Common vs. Apogee Enterprises
Performance |
| Timeline |
| Rapport Therapeutics, |
| Apogee Enterprises |
Rapport Therapeutics, and Apogee Enterprises Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rapport Therapeutics, and Apogee Enterprises
The main advantage of trading using opposite Rapport Therapeutics, and Apogee Enterprises positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rapport Therapeutics, position performs unexpectedly, Apogee Enterprises can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Enterprises will offset losses from the drop in Apogee Enterprises' long position.| Rapport Therapeutics, vs. Cresud SACIF y | Rapport Therapeutics, vs. Griffon | Rapport Therapeutics, vs. Cardinal Health | Rapport Therapeutics, vs. Park Electrochemical |
| Apogee Enterprises vs. Quanex Building Products | Apogee Enterprises vs. Janus International Group | Apogee Enterprises vs. Interface | Apogee Enterprises vs. Azek Company |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |